{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T20:33:00Z","timestamp":1648672380851},"reference-count":22,"publisher":"Japanese Urological Association","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn. j. urol"],"published-print":{"date-parts":[[2011]]},"DOI":"10.5980\/jpnjurol.102.14","type":"journal-article","created":{"date-parts":[[2012,6,10]],"date-time":"2012-06-10T22:31:03Z","timestamp":1339367463000},"page":"14-22","source":"Crossref","is-referenced-by-count":1,"title":["BLADDER PRESERVATION USING CHEMORADIATION THERAPY FOR LOCALLY INVASIVE BLADDER CANCER"],"prefix":"10.5980","volume":"102","author":[{"given":"Toyofumi","family":"Abe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mototaka","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-Ichiro","family":"Sekii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Itatani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4001","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Ott O.J., Rodel C., Weiss C., Wittlinger M., St Krause F., Dunst J., Fietkau R. and Sauer R.: Radiochemotherapy for bladder cancer. Clin Oncol (R Coll Radiol) , 21, 557-565, 2009.","DOI":"10.1016\/j.clon.2009.05.005"},{"key":"2","unstructured":"2) Zietman A.L. and Shipley W.U., eds.: Bladder cancer. In Gunderson LL and JE, Eds. Clinical Radiation Oncology, p 1237-1260, Elsevier, 2006."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Utsunomiya M., Itoh H., Yoshioka T., Masaki N. and Itatani H.: Preliminary results of concurrent cisplatin and radiation therapy in locally advanced bladder cancer. Br J Urol, 70, 399-403, 1992.","DOI":"10.1111\/j.1464-410X.1992.tb15796.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Pollack A., Wu C.S., Czerniak B., Zagars G.K., Benedict W.F. and McDonnell T.J.: Abnormal bcl-2 and pRb expression are independent correlates of radiation response in muscle-invasive bladder cancer. Clin Cancer Res, 3, 1823-1829, 1997.","DOI":"10.1016\/S0360-3016(97)00147-8"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(95)00060-C"},{"key":"6","doi-asserted-by":"crossref","unstructured":"7) Sternberg C.N., Donat S.M., Bellmunt J., Millikan R.E., Stadler W., De Mulder P., Sherif A., von der Maase H., Tsukamoto T. and Soloway M.S.: Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer. Urology, 69, 62-79, 2007.","DOI":"10.1016\/j.urology.2006.10.041"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(93)90306-G"},{"key":"8","doi-asserted-by":"crossref","unstructured":"10) Yoshida S., Koga F., Kawakami S., Ishii C., Tanaka H., Numao N., Sakai Y., Saito K., Masuda H., Fujii Y. and Kihara K.: Initial experience of diffusion-weighted magnetic resonance imaging to assess therapeutic response to induction chemoradiotherapy against muscle-invasive bladder cancer. Urology, 75, 387-391, 2010.","DOI":"10.1016\/j.urology.2009.06.111"},{"key":"9","doi-asserted-by":"crossref","unstructured":"11) Miyanaga N., Akaza H., Hinotsu S., Joraku A., Oikawa T., Sekido N., Kawai K. and Shimazui T.: Background Variables for the Patients with Invasive Bladder Cancer Suitable for Bladder-preserving Therapy. Jpn J Clin Oncol, 37, 852-857, 2007.","DOI":"10.1093\/jjco\/hym129"},{"key":"10","doi-asserted-by":"crossref","unstructured":"13) Hashine K., Kusuhara Y., Miura N., Shirato A., Sumiyoshi Y. and Kataoka M.: Bladder preservation therapy conducted by intra-arterial chemotherapy and radiotherapy for muscle invasive bladder cancer. Jpn J Clin Oncol, 39, 381-386, 2009.","DOI":"10.1093\/jjco\/hyp023"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.11.027"},{"key":"12","doi-asserted-by":"crossref","unstructured":"15) Pos F.J., Hart G., Schneider C. and Sminia P.: Radical radiotherapy for invasive bladder cancer: What dose and fractionation schedule to choose? Int J Radiat Oncol Biol Phys, 64, 1168-1173, 2006.","DOI":"10.1016\/j.ijrobp.2005.09.023"},{"key":"13","doi-asserted-by":"crossref","unstructured":"16) Rodel C., Grabenbauer G.G., Kuhn R., Zorcher T., Papadopoulos T., Dunst J., Schrott K.M. and Sauer R.: Organ preservation in patients with invasive bladder cancer: initial results of an intensified protocol of transurethral surgery and radiation therapy plus concurrent cisplatin and 5-fluorouracil. Int J Radiat Oncol Biol Phys, 52, 1303-1309, 2002.","DOI":"10.1016\/S0360-3016(01)02771-7"},{"key":"14","unstructured":"17) Douglas R.M., Kaufman D.S., Zietman A.L., Althausen A.F., Heney N.M. and Shipley W.U.: Conservative surgery, patient selection, and chemoradiation as organ-preserving treatment for muscle-invading bladder cancer. Semin Oncol, 23, 614-620, 1996."},{"key":"15","doi-asserted-by":"crossref","unstructured":"19) Kroemer G.: The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med, 3, 614-620, 1997.","DOI":"10.1038\/nm0697-614"},{"key":"16","doi-asserted-by":"crossref","unstructured":"20) Matsumoto H., Wada T., Fukunaga K., Yoshihiro S., Matsuyama H. and Naito K.: Bax to Bcl-2 ratio and Ki-67 index are useful predictors of neoadjuvant chemoradiation therapy in bladder cancer. Jpn J Clin Oncol, 34, 124-130, 2004.","DOI":"10.1093\/jjco\/hyh026"},{"key":"17","doi-asserted-by":"crossref","unstructured":"21) Pollack A., Cowen D., Troncoso P., Zagars G.K., von Eschenbach A.C., Meistrich M.L. and McDonnell T.: Molecular markers of outcome after radiotherapy in patients with prostate carcinoma: Ki-67, bcl-2, bax, and bcl-x. Cancer, 97, 1630-1638, 2003.","DOI":"10.1002\/cncr.11230"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-2972"},{"key":"19","doi-asserted-by":"crossref","unstructured":"23) Koga F., Kihara K., Fujii Y., Yoshida S., Saito K., Masuda H., Kageyama Y. and Kawakami S.: Favourable outcomes of patients with clinical stage T3N0M0 bladder cancer treated with induction low-dose chemo-radiotherapy plus partial or radical cystectomy vs immediate radical cystectomy: a single-institutional retrospective comparative study. BJU Int, 104, 189-194, 2009.","DOI":"10.1111\/j.1464-410X.2008.08297.x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"24) Koga F., Yoshida S., Kawakami S., Kageyama Y., Yokoyama M., Saito K., Fujii Y., Kobayashi T. and Kihara K.: Low-dose chemoradiotherapy followed by partial or radical cystectomy against muscle-invasive bladder cancer: an intent-to-treat survival analysis. Urology, 72, 384-388, 2008.","DOI":"10.1016\/j.urology.2008.03.017"},{"key":"21","doi-asserted-by":"crossref","unstructured":"25) Kent E., Sandler H., Montie J., Lee C., Herman J., Esper P., Fardig J. and Smith D.C.: Combined-modality therapy with gemcitabine and radiotherapy as a bladder preservation strategy: results of a phase I trial. J Clin Oncol, 22, 2540-2545, 2004.","DOI":"10.1200\/JCO.2004.10.070"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2008.09.036"}],"container-title":["The Japanese Journal of Urology"],"original-title":["\u6d78\u6f64\u6027\u8180\u80f1\u764c\u306b\u5bfe\u3059\u308b\u653e\u5c04\u7dda\u5316\u5b66\u7642\u6cd5\u2015\u6cbb\u7642\u6210\u7e3e\u3068\u4e88\u5f8c\u4e88\u6e2c\u56e0\u5b50\u3068\u3057\u3066\u306eBcl-2 family\u2015"],"language":"en","deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T22:27:09Z","timestamp":1621549629000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jpnjurol\/102\/1\/102_14\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.5980\/jpnjurol.102.14","relation":{},"ISSN":["0021-5287","1884-7110"],"issn-type":[{"value":"0021-5287","type":"print"},{"value":"1884-7110","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011]]}}}